Comparison of five-day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based regimens with and without omeprazole pretreatment.
Background: The onset of antisecretory activity of rabeprazole is faster than that of omeprazole.Objective: This study was performed to compare the efficacy of short-term rabeprazole-based triple therapy with that of omeprazole-based triple therapy and to determine the influence of omeprazole pretre...
| Publicado en: | Current Therapeutic Research Vol. 64; no. 7; pp. 412 - 422 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | clinical trial research tables/charts Journal Article |
| Publicado: |
Elsevier B.V.
Jul2003
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106753987&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106753987 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0011393X KIH jtl: Current Therapeutic Research issn: 0011393X maglogo: N pubinfo: dt: Jul2003 vid: 64 iid: 7 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 106753987 106753987 2004114514 10.1016/s0011-393x(03)00120-6 106753987 ppf: 412 ppct: 10 formats: tig: atl: Comparison of five-day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based regimens with and without omeprazole pretreatment. aug: au: Adachi K Hashimoto T Ishihara S Fujishiro H Sato S Sato H Amano Y Hattori S Kinoshita Y affil: Second Dept of Internal Medicine, Shimane Medical University, 89-1 Enya-cho, Izumo-shi, Shimane 693-8501, Japan; kadachi@shimane-med.ac.jp sug: subj: Helicobacter Infections Drug Therapy Proton Pump Inhibitors Therapeutic Use Adult Aged, 80 and Over Amoxicillin Adverse Effects Amoxicillin Therapeutic Use Chi Square Test Clarithromycin Adverse Effects Clarithromycin Therapeutic Use Clinical Trials Comparative Studies Descriptive Statistics Female Kruskal-Wallis Test Male Mann-Whitney U Test Middle Age Proton Pump Inhibitors Adverse Effects Funding Source Human Adult: 19-44 years Aged, 80 & over Middle Aged: 45-64 years Female Male ab: Background: The onset of antisecretory activity of rabeprazole is faster than that of omeprazole.Objective: This study was performed to compare the efficacy of short-term rabeprazole-based triple therapy with that of omeprazole-based triple therapy and to determine the influence of omeprazole pretreatment in omeprazolebased short-term triple therapy.Methods: This was a 2-center, open-label, prospective, randomized study. Patients who tested positive for Helicobacter (formerly Campylobacter) pylori were randomized to one of three 5-day regimens: (1) rabeprazole 20 mg BID, amoxicillin 500 mg TID, and clarithromycin 400 mg BID (RAC group); (2) omeprazole 20 mg BID, amoxicillin 500 mg TID, and clarithromycin 400 mg BID without omeprazole pretreatment (OAC 1 group); and (3) omeprazole 20 mg BID, amoxicillin 500 mg TID, and clarithromycin 400 mg BID with 5 days of omeprazole pretreatment 20 mg BID (OAC2 group). Eradication was assessed by 13C-urea breath test and rapid urease test ~1 month after completion of treatment. All patients who entered this study were included in the intent-to-treat (ITT) analysis, patients who completed the study were included in the perprotocol (PP) analysis, and patients who did not undergo the 13C-urea breath test and rapid urease test were included in the all-patients-treated (APT) analysis.Results: A total of 120 patients (86 men, 34 women; mean [SD] age, 55.8 [14.3] years; range, 19-86 years) were assigned to the RAC, OAC1, or OAC2 group (40 patients in each group). ITT, PP, and APT eradication rates in the RAC group were 90%, 92%, and 90%, respectively; in the OAC1 group, 75%, 83%, and 75%; and in the OAC2 group, 85%, 90%, and 87%. These eradication rates were not significantly different between groups.Conclusions: Eradication rates did not differ significantly between the three 5-day proton pump inhibitor-based triple therapies in this study population. However, 5-day rabeprazole-based triple therapy tends to be more effective than 5-day omeprazole-based triple therapy in the eradication of H pylori, and treatment with omeprazole before eradication therapy may improve the eradication rates of 5-day omeprazole-based therapy. pubtype: Academic Journal doctype: clinical trial research tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|